Sep 6
|
Unraveling the Future of Catalyst Pharmaceuticals Inc (CPRX): A Deep Dive into Key Metrics
|
Aug 11
|
Catalyst Pharmaceuticals Second Quarter 2023 Earnings: EPS: US$0.35 (vs US$0.21 in 2Q 2022)
|
Aug 9
|
Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates
|
Aug 9
|
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
|